Harrison & Star lands Roche Pegasys account

Share this article:
Roche switched professional agencies for its top-selling hepatitis C therapy Pegasys to Omnicom’s Harrison & Star from echo Torre Lazur, part of Interpublic Group’s McCann Healthcare Worldwide. The move followed a three-way pitch among Harrison & Star, GSW and one other agency. Pegasys is the world’s best-selling treatment for chronic hepatitis C. The drug brought in $1.13 billion in revenue last year, a 17% increase over 2004.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions